Text Size decrease text size increase text size
 
News
Exhibitions
Clinical Data
Updates
Useful Links
search
Text Size decrease text size increase text size
Home  /  News  /  Updates  /  
Korean FDA cleared DirexGroup’s Renova for ED Treatment

May. 4, 2018

DirexGroup, a global medical device company focused on the field of urology with a strong emphasis on product development and innovation, announced today that it has received approval from the Korean Food & Drug Administration (KFDA) for Erectile Dysfunction treatment by Renova.

Renova applies Linear Low Intensity Shockwaves (LLISW) which promotes angiogenesis - a natural process of new blood vessel formation. The process restores blood supply on a micro-vascular level, thus improving erectile function in men experiencing vascular  erectile weakness.

Renova is the only device offering coverage of penis and crura linear segments due to a unique Linear applicator. Consequently, Renova offers the shortest protocol of four weekly sessions - 20 minutes per session. Efficacy of up to 80% success rate is documented by worldwide KOL's at http://www.direxgroup.com/files/27ecc736cbdc73c24213b7ede15a4b62.pdf

 "I am pleased and excited about receiving Renova approval from KFDA which treats Erectile Dysfunction" says Byung Ki Kim, Manager of Direx Korea. "Success in the international markets ensure great business for this treatment in Korea. Renova treatment is painless, does not require anesthesia and has no known side effects. The unique Linear  technology of Renova treatment, has quickly become the preferred choice of treatment for healthcare professionals and patients seeking a spontaneous and satisfactory sexual life"

KFDA approval in Korea is the most recent of regulatory clearances for Renova, adding to its existing regulatory approvals which include CE, ANVISA, CFDA, RZN, SFDA, MOH and HAS.

"As we expand to new markets globally," says Dr. Moshe Ein-Gal of DirexGroup, "we will continue to invest in research and development, intellectual property and clinical studies that will help us expand our applications and create innovative products and technologies. South Korea is a very important market and I expect continued global regulatory approvals this year."

About DirexGroup
DirexGroup specializes in providing innovative devices for urologists in all worldwide markets. Established 35 years ago, DirexGroup has continuously extended its worldwide presence in numerous countries and markets. The Group has put its emphasis on the field of urology and offers urologists and medical centers various equipment and service solutions to their clinical and economic needs. The products are reliable, modular and transportable, as well as offering cost effectiveness and ease of use. Support and maintenance is provided by a worldwide network of committed and competent service centers.

Contact DirexGroup at info@direxgroup.com





Additional News:
"The sole clinical trial using shockwave therapy in the United States" (healthline.com)
Direx Participated in Africa Health 2018
Dr. Ranjith Ramasamy Reports on First Clinical Trials Using Shockwave Therapy to Treat ED
Direx introduces TEMPRO in Indonesia
DirexGroup is Geared for Growth
Renova Symposium Hanoi, Vietnam
Regional Sales Training takes place in Istanbul
Direx Announces Saudi FDA Approval for Renova
Direx launches in the Philippines
Dual Shockwaves with High-flow Oxygen may Improve Lithotripsy Results
DirexGroup will exhibit MoreNova at the upcoming EAU exhibition in London UK, March 24 -28, 2017.
DirexGroup extends sincere congratulations and warm wishes to Dr. Cobi Reisman
MoreNova - Treating a Seated Patient without Transducer Repositioning
Renova in Shanghai, China
DirexGroup's Increases its Worldwide presence
Leading doctors to introduce new perspectives at 16th Course on Andrology by Fundació Puigvert - Barcelona
ISSM 2016: World Meeting on Sexual Medicine
Dr. Natalio Cruz will be presenting his experience at a Symposium in Colombia
Two Renova studies incorporated in Prof Tom Lue’s (UCSF) Meta Analysis of Low Intensity Shockwaves for ED patients.
Long Term results of LISW Therapy for ED patients who are PDE-5i Non Responders
Direx Systems Corp Receives 2016 Best of Canton Award
Renova treatment for ED now available in Brazil
Direx Argentina - Decade of Excellence
Renova for ED treatment, as presented in a seminar in Oviedo, may avert heart attacks and strokes
Renova in Japan - 2nd Generation LISW for ED
Renova Presentation - 20 month follow up
New study shows notable results of Renova for PDE5i non-responder patients
Renova Reaches new Markets
Direx Impacts at ISSM/SLAMS Exhibition in Sao Paulo
Direx expands its presence in the Middle East
Renova treatments available at several leading centers in Indonesia
Largest Multi Center Clinical Trial of Low Intensity SW for Erectile Dysfunction
Two leading Urologists will be presenting their experience with Renova at the upcoming ISSM/SLAMS exhibition
DirexGroup, together with its local representative R9C, will have a very large presence at the upcoming ISSM/SLAMS exhibition
DirexGroup presented the RENOVA system at the LXXIX Congreso Nacional de Urología, which took place on June 11-14 in Tenerife, Spain.
Dr. Antonio Martin Morales speaks about Renova treatment for Erectile Dysfunction
DirexGroup presents comprehensive product line for Urology
Dr, Cruz is appointed Secretary General of the European Society for Sexual Medicine
Dr. Antonio Martin Morales, one of the first pioneer Renova users, is awarded the European Society of Sexual Medicine (ESSM) 2014 Career Award
Renova receives regulatory approval in Colombia and Mexico
Renova treatment for ED patients at the prestigious Tenon Hospital in Paris
Renova treatments in the prestigious "Hopital Tenon " in Paris
Renova treatment for ED - a success in the Czech Republic
Low Intensity Shockwave for ED treatment to be presented at ESSM conference
In-Line and On-Line fluoroscopy with Integra Lithotripter, was presented at WCE by Dr Munoz
Integra Lithotripsy study to be presented at the upcoming World Congress of Endourology
Renova, the dedicated device offering LSWT
DirexGroup's recently launched Renova is making waves at the European Association of Urology (EAU)
Renova Generates Unprecedented Interest at European Society of Sexual Medicine Congress, Amsterdam
Second Generation Device Dedicated to Erectile Dysfunction Treatment
A Panel of Distinguished Latin American Users Discussed Electromagnetic SWL at CNN Theater in Atlanta, GA
DirexGroup Announces New General Manger for its European Headquarters
Direx Mexico impacts at Mexican Urological Society (SMU) Congress, Los Cabos, Mexico
Attractions at the Urological Congress of Buenos Aires, Argentina
Doctors Hospital in Monterrey, Mexico opens its doors with Duet Magna Lithotripsy for its Patients
Treatment Results with Integra was Presented at 180th JUA Kumamoto Regional Meeting
RF Thermal Therapy Treatment for CPPS Presented at ESSM Congress in Malaga, Spain
Darent Valley Hospital Renews Contract with DirexGroup
Initial results of MAGNA in Latin America presented at CAU Congress in Chile
DirexGroup signs distribution agreement with Mayumana Health for improved service in the Netherlands
Seminar, in Germany, introduces new prostatitis treament
DirexGroup strengthens its presence at this months 103èmes Congrès Français d’Urologie
Two papers presented at WCE in Munich, Germany
Direx-Initia in the UK
Introducing Chronic Abacterial Prostatitis / CPPS , treatment with Tempro Thermotherapy System
DirexGroup Exhibited at the WCE in Shanghai
Direx Japan successfully launches the specially designed Electromagnetic Integra
Direx Korea Achieves KFDA Approval for Tempro BPH Treatment System
Direx Brazil, Direx Mexico and Direx Argentina Offer Holmium Laser Systems
Doctors Hospital in Monterrey, Mexico Opens its Doors with Duet Magna Lithotripsy for its Patients